as 10-24-2025 3:52pm EST
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Upcoming Earnings Alert:
Get ready for potential market movements as TransMedics Group Inc. TMDX prepares to release earnings report on 29 Oct 2025.
| Founded: | 1998 | Country: | United States |
| Employees: | N/A | City: | ANDOVER |
| Market Cap: | 4.0B | IPO Year: | 2019 |
| Target Price: | $128.92 | AVG Volume (30 days): | 868.2K |
| Analyst Decision: | Buy | Number of Analysts: | 12 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 2.02 | EPS Growth: | 2163.11 |
| 52 Week Low/High: | $55.00 - $145.50 | Next Earning Date: | 10-29-2025 |
| Revenue: | $531,292,000 | Revenue Growth: | 48.09% |
| Revenue Growth (this year): | 38.78% | Revenue Growth (next year): | 20.76% |
TMDX Breaking Stock News: Dive into TMDX Ticker-Specific Updates for Smart Investing
Simply Wall St.
18 days ago
Motley Fool
19 days ago
Simply Wall St.
a month ago
Insider Monkey
2 months ago
Zacks
2 months ago
Motley Fool
4 months ago
Simply Wall St.
4 months ago
Zacks
4 months ago
The information presented on this page, "TMDX TransMedics Group Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.